Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300123
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,566
Award facts
- Contract value 50% obligated
-
- $14,566.14 Current, with exercised options
- $29,132.28 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the Office of the Director, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, has a ceiling value of $29,132.28 and an ultimate completion date of December 31, 2013. The contract is for DRUGS AND BIOLOGICALS and does not have a set-aside designation, indicating it was competitively awarded.
Roche Diagnostics Corporation is a global leader in diagnostic solutions and has multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across federal agencies, including a $37 million BPA with the Defense Health Agency for immunochemistry and clinical chemistry testing, and several Veterans Affairs-specific IDCs with ceiling values ranging from $208,000 to $3.1 million. These contract vehicles enable federal agencies to efficiently acquire Roche's medical diagnostic technologies through pre-negotiated pricing and terms, supporting healthcare delivery across military, veterans, and civilian healthcare systems.
Quick answers
Who was awarded contract HHSN26300123?
HHSN26300123 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on June 5, 2013.
How much is contract HHSN26300123 worth?
The government has obligated $14,566 on HHSN26300123. Its potential value, with all options, is $29,132.
Is contract HHSN26300123 an order under another contract?
Yes. HHSN26300123 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26300123 competed?
The extent of competition for HHSN26300123 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award